Evidence map›Paper›PMID 41268414›Full record

ArticleFrontiers in public health2025

Incidence and persistent infection rates of type-specific HPV among HIV-infected males in China: a 5-year retrospective study.

Siwei Zhang, Huan Liu, Zhiyan Huang, Siyu Duan, Yuting Zhang, Yanjing Li, Wenzhu Chu, Yan Wang, Rongqing Yang, Lanlan Wei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Siwei Zhang *National Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Huan Liu *Department of Endodontics, The First Affiliated Hospital of Harbin Medical University, School of Stomatology, Harbin Medical University, Harbin, China.
Zhiyan HuangSchool of Public Health, Guangzhou Medical University, Guangzhou, China.
Siyu DuanNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Yuting ZhangDepartment of Endodontics, The First Affiliated Hospital of Harbin Medical University, School of Stomatology, Harbin Medical University, Harbin, China.
Yanjing LiLaboratory of Medical Genetics, Harbin Medical University, Harbin, China.
Wenzhu ChuDepartment of Dermatology and Venereology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Yan WangDepartment of Microbiology, Harbin Medical University, Harbin, China.
Rongqing YangDepartment of Dermatology and Venereology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Lanlan WeiNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although the 9-valent HPV vaccine (9v-HPV) has been approved for males in China, it has received limited public attention. This study aimed to explore the incidence and persistence of different HPV types in HIV-related males and emphasize the importance of vaccination. Methods: A cohort of 758 male patients with multiple HPV detection (≥3) from 2018 to 2023 in our hospital were enrolled for statistical analysis, including 113 Men who have Sex with Men (MSM) patients. HIV and HPV infection statuses were confirmed respectively by ELISA, PCR, WB and nucleic acid kit. Results: Statistical analysis revealed that the incidence of 9v-HPV-covered high-risk (HR) HPV infections were 68.1% (HIV Discussion: These findings highlight the increased burden of HPV infection among HIV

Indexed as

HIV InfectionsPapillomaviridaePapillomavirus InfectionsPersistent InfectionAdultChinaHomosexuality, MaleHumansIncidenceMaleMiddle AgedPapillomavirus VaccinesRetrospective StudiesPapillomavirus VaccinesHIVHPV vaccineshuman papillomavirusmen who have sex with mensexually transmitted diseases

Identifiers

PMID41268414
PMCPMC12627005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.